Marc Goldberg Insider Profile
4 Followers
Marc Goldberg, Director at Enanta Pharmaceuticals, holds 547.61K shares in Enanta Pharmaceuticals (Ticker: ENTA). Most recently, Marc Goldberg Sold 6,861 shares of Enanta Pharmaceuticals on Dec 06, 2013 for an estimated value of $191.56K.
Marc Goldberg's Trading History
| ENTAEnanta Pharmaceuticals | Dec 06, 2013 | Director | Informative Sell | 191.56K | $5.84M | |
You May Also Like
Marc Goldberg insider profile FAQ
What is the percentage of profitable transactions made by Marc Goldberg?
The percentage of profitable transactions made by Marc Goldberg is 0%.
What is the average return per transaction made by Marc Goldberg?
The average return per transaction made by Marc Goldberg is -74.30%.
What stocks does Marc Goldberg hold?
Marc Goldberg holds: ENTA stocks.
What was Marc Goldberg’s latest transaction?
Marc Goldberg’s latest transaction was an Informative Sell of $191.56K.
What was Marc Goldberg's most profitable transaction?
Marc Goldberg’s most profitable transaction was an Informative Sell of ENTA stock on December 6, 2013. The return on the trade was -70.90%.
What is Marc Goldberg's role in Enanta Pharmaceuticals?
Marc Goldberg's role in Enanta Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
